Taiba Healthcare

What Taiba Healthcare does

Taiba Healthcare is a privately held healthcare group headquartered in the Rusail Industrial Area of Muscat, Oman. The company has operated since 1997 and positions itself as a regional healthcare provider serving patients and healthcare organizations across the MENA region. Its offering is organized into four categories: pharmaceutical products and medicines, specialized medical treatments, health management solutions, and preventive care resources. The company emphasizes quality assurance, patient-centered service, and supply chain reliability as differentiators, and maintains a dedicated pharmacovigilance channel ([email protected]).

The business model combines direct-to-patient provision of pharmaceutical and clinical services with a partnership channel serving healthcare professionals and institutional buyers. Distribution is regional across MENA, with marketing and brand presence maintained primarily through LinkedIn and Instagram, supplemented by a corporate website and blog. Leadership is concentrated under CEO Saif Al Hasani. No pricing model, customer contract structure, or revenue mechanics are publicly disclosed.

The company operates without documented funding rounds, M&A activity, third-party partnerships, certifications, or proprietary technology platforms. There is no mobile application, API, or disclosed technology stack beyond standard web infrastructure. The absence of disclosed financial metrics, headcount, and strategic transaction history materially limits visibility into scale, unit economics, and growth dynamics, and is the primary diligence gap for any prospective investor or acquirer.

Name

Taiba Healthcare

Legal name

Taiba Healthcare

Website

https://taibahealthcare.com

Company type

Private

Founded year

1997

Operating status

Operating

Short description

Taiba Healthcare is a privately held Oman-based healthcare group providing pharmaceutical products, specialized treatments, health management solutions, and preventive care to patients and healthcare organizations across the MENA region.

Ownership category

akta.pro rank

Product category

Pharmaceutical & Healthcare Services

NAICS

Health Care and Social Assistance (62)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Services-Health Services (8000)

akta.pro primary industry

Medical Supplies & Consumables Wholesale (Non-Device) (CRAOAHAE)

Keywords

• Pharmaceutical distribution
• Healthcare services
• Preventive care
• Health management solutions
• Specialized medical treatments

Headquarters

HQ city

Muscat

HQ country

Oman

HQ region

Middle East

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Supply Chain, Operations, Marketing or Sales

Distribution channels1 record

Marketing channels2 records

Core offering

Taiba Healthcare distributes pharmaceutical products and medicines and delivers a comprehensive suite of healthcare services—including specialized medical treatments, health management solutions, and preventive care resources—to patients and healthcare organizations across the MENA region, operating from its base in Muscat, Oman.

Product overview

Taiba Healthcare operates as a single unified healthcare services platform offering pharmaceutical products and medicines alongside specialized treatments, health management solutions, and preventive care resources. The company serves patients across the MENA region from its base in Muscat, Oman, providing holistic and tailored healthcare solutions through a comprehensive approach that addresses all aspects of patient well-being under one roof.

Differentiator

Problem solved

Functional benefit

Products and services

• Pharmaceutical Products and Medicines
• Specialized Treatments
• Health Management Solutions
• Preventive Care Resources

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves3 records

Expansion highlights4 records

Direct peers

• Julphar (Gulf Pharmaceutical Industries): UAE-headquartered regional pharmaceutical manufacturer and distributor serving MENA markets. Directly comparable to Taiba in product category, customer base (patients and healthcare providers), and regional distribution model.
• SPIMACO (Saudi Pharmaceutical Industries & Medical Appliances): Saudi Arabia-based pharmaceutical manufacturer and distributor with a regional MENA footprint. Comparable in offering branded and generic medicines to institutional and retail customers across the same geographies as Taiba.
• Tabuk Pharmaceuticals: Saudi-headquartered pharmaceutical company developing, manufacturing, and distributing branded generics across MENA. Directly comparable product/customer overlap with Taiba's pharmaceutical distribution business.
• Hikma Pharmaceuticals: Jordan-headquartered multinational pharmaceutical company with a strong MENA branded and injectable portfolio. Comparable business model (manufacture plus distribution) and customer base in the same regional markets as Taiba.
• EIPICO (Egyptian International Pharmaceutical Industries): One of the largest pharmaceutical manufacturers in Egypt with MENA-wide distribution. Comparable in product category (human medicines), customer segments, and regional distribution to Taiba.

Regional players

• Dallah Healthcare Holding: Saudi-based healthcare group operating hospitals, clinics, and pharmaceutical services across MENA. Comparable as a regional integrated healthcare services player; primary operations are Saudi rather than Omani.
• NMC Healthcare: UAE-based integrated private healthcare provider with pharmaceutical distribution and patient-care services. Comparable integrated healthcare platform model, though primarily UAE-focused.

Emerging players

• Aspen Pharmacare: South Africa-headquartered specialty pharmaceutical group with growing MENA presence post-AstraZeneca and GSK acquisitions. Comparable in product portfolio depth and regional expansion ambition.

Broad incumbents

• GSK (GlaxoSmithKline): Global pharmaceutical incumbent with established MENA distribution networks and a broad branded portfolio. Comparable in product category and customer base; not regional but sets the competitive standard Taiba faces.
• Pfizer: Global pharmaceutical incumbent with direct MENA operations and a broad therapeutic portfolio. Comparable as a competitor for the same patient and institutional customers, though at vastly larger scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/taiba-healthcare
• Instagraminstagram.com/taiba.healthcare

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Taiba Healthcare